The Effect of Balanced Anesthesia Regimen on Intraoperative Trans-cranial Motor Evoked Potential During Spine Surgeries:

NCT ID: NCT04997707

Last Updated: 2021-08-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-04-06

Study Completion Date

2021-04-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

transcranial motor evoked potentials (TcMEP) were proved to be useful during complicated spinal surgeries to prevent iatrogenic complications. The effect of anesthetic agents was comprehensively discussed in literature. The Investigators studied a new balanced anesthetic protocol using propofol and sevoflurane in addition to continuous fentanyl infusion in which they compared values and ratios of amplitudes and latencies of TcMEP waves at different time point.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective double- blind randomized controlled study. After approval by the ethics committee at the National Cancer Institute (Cairo University) and El-Sahel Teaching Hospital (GOHTI, Cairo) and after written informed consents,46 ASA I-II patients who are scheduled for various spinal surgeries (such as: intra-spinal tumor resection, spondylolisthesis correction, traumatic spinal fractures' fixation,…) will be included in this study. Surgeons and neurophysiologists will be the same and will be blind to the anesthetic techniques in all patients.

Randomization list will be generated then patients will be randomized into two groups: control and study group.

Preoperatively, all patients will be checked for any exclusion criteria and the routine preoperative evaluation will be done. On arriving operative theater, all patients will receive 0.1 mg/kg midazolam IV. After connecting all the basic monitors' cables (NIBP, pulse oximetry and ECG) and canulating the radial artery to monitor IBP, induction of anesthesia will be done to all patients with 4μg/kg fentanyl, 2-3mg/kg propofol IV and 0.5mg/kg atracurium to facilitate endotracheal intubation. After intubation, central venous catheter( CVP), temperature probe through nasopharynx and urinary catheter will be inserted. Fentanyl infusion will be maintained in a rate of 2μg/kg/hour and will be discontinued 60 minutes before recovery.

From this time on, patients will be randomly allocated into control and study groups, each group is 30 patients; control group is the propofol (P) group and the study group is the balanced anesthesia (BA) group.

Control Group: propofol will be infused continuously in a rate of 75-100 μg/kg/min Study Group: propofol infusion in a rate of 25μg/kg/min will be given with sevoflurane. Sevoflurane concentration will be individually calculated by age-adjusted end - tidal MAC as follows: for age of 18-25 years, 26-40 years and ≥40 years MAC will be 2.6%, 2.2% and 1.8% respectively then final concentration to be delivered will be 0.2% lower than calculated half MAC.

Patients will be mechanically ventilated with O2/Air mixture (FiO2 50%) in a rate of 10-12/minute and tidal volume of 6-8 ml/kg to insure oxygen saturation (SpO2) around 99% and end-tidal CO2 between 28-35 mmHg. Body temperature must be kept between 35-37oC( Celsius degrees) using warm fluids and warming blankets.

Intraoperative fluids will be given guided by central venous pressure (CVP)and urine output.

Hypotension ( mean arterial blood pressure (MAP) ˂60 mmHg in normotensive patients or ˂70 mmHg in hypertensive patients) will be treated with Norepinephrine (Levophed®) in an infusion of 0.05-1.0μg /kg/min.

TcMEP Monitoring:

After induction, transcranial stimulation electrode will be connected at C1- C2, Cz and C3-C4 (10-10 international system) and subdermal needles inserted in the appropriate muscles, according to the scenario selected, processing will be done using NIM-SPINE™ SYSTEM (2005 Medtronic Sofamor Danek USA, Inc.). The stimulation used is a train-of-five square wave stimulation, 2ms inter-stimulus interval, 500 μs width and 40-220 mA intensity which can be increased with 10 mA steps till muscle answer potential is recorded.

The first TcMEP (R1) will be taken before positioning and surgical incision, at least 20-25 minutes after induction; fading of the neuromuscular blockade will be checked by train-of-four (TOF) and double- burst stimulation using peripheral nerve stimulator connected to the ulnar nerve.

A second reading (R2), which is the surgical baseline reading, will be taken 20 minutes later; during which positioning of the patient is done; again muscle relaxant fading is confirmed before the reading as above. A third reading (R3) will be taken after the surgical incision.

With every TcMEP reading, MAP, pulse rate, Oximetry, En-tidal CO2, nasopharyngeal temperature, ulnar train-of-four response, sevoflurane percentage concentration / propofol infusion rate and CVP will be recorded.

Comparison between R1 and R2 will be dedicated to the effect of anesthetic regimen, while subsequent readings will indicate both the effect of anesthetic regimen and any surgical insult (if any).

Decrease in every wave amplitude by more than 50% in relation to R1 and increase in latency more than 2 ms will be recorded as an alarming criterion.

On recovery:

After fulfilling the Modified Aldrete Recovery Score, patients will be discharged from postoperative recovery unit (PACU) to the intermediate care unit. All patients with an alarming criterion will be checked by neurosurgeon for any motor deficit.

Sample size estimation:

The aim of this study is to compare the effects of balanced anesthesia using low dose propofol and less than half MAC sevoflurane versus propofol based anesthesia while using medium-dose fentanyl in both techniques on TcMEP intraoperative monitoring during spine surgeries. Based on the previous paper published by Palazon et al., 2015, the difference in latency between the 2 groups was 3 with an average variability of 3. A total sample size of 46 (23 per group) will be sufficient to detect that effect size, with power 90% and 5% significance level the sample size was calculated by the G power program.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Motor Evoked Potential

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

P group

75-100 µg/kg/min propofol

Group Type ACTIVE_COMPARATOR

Propofol Abbott

Intervention Type DRUG

in a rate of 75-100 μg/kg/min in P group, and 25μg/kg/min in BA group

transcranial motor evoked potential(Tcm

Intervention Type DIAGNOSTIC_TEST

using NIM-SPINE™ SYSTEM (2005 Medtronic Sofamor Danek USA, Inc.). The stimulation used is a train-of-five square wave stimulation, 2ms inter-stimulus interval, 500 μs width and 40-220 mA intensity which can be increased with 10 mA steps till muscle answer potential is recorded.

BA group

25ug/kg/min propofol and 0.2% below corrected-to-age- half MAC of sevoflurane

Group Type ACTIVE_COMPARATOR

Propofol Abbott

Intervention Type DRUG

in a rate of 75-100 μg/kg/min in P group, and 25μg/kg/min in BA group

Sevoflurane Inhalation Solution

Intervention Type DRUG

in BA group will be calculated by age-adjusted end - tidal MAC as follows: for age of 18-25 years, 26-40 years and ≥40 years MAC will be 2.6%, 2.2% and 1.8% respectively then final concentration to be delivered will be 0.2% lower than calculated half MAC.

transcranial motor evoked potential(Tcm

Intervention Type DIAGNOSTIC_TEST

using NIM-SPINE™ SYSTEM (2005 Medtronic Sofamor Danek USA, Inc.). The stimulation used is a train-of-five square wave stimulation, 2ms inter-stimulus interval, 500 μs width and 40-220 mA intensity which can be increased with 10 mA steps till muscle answer potential is recorded.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Propofol Abbott

in a rate of 75-100 μg/kg/min in P group, and 25μg/kg/min in BA group

Intervention Type DRUG

Sevoflurane Inhalation Solution

in BA group will be calculated by age-adjusted end - tidal MAC as follows: for age of 18-25 years, 26-40 years and ≥40 years MAC will be 2.6%, 2.2% and 1.8% respectively then final concentration to be delivered will be 0.2% lower than calculated half MAC.

Intervention Type DRUG

transcranial motor evoked potential(Tcm

using NIM-SPINE™ SYSTEM (2005 Medtronic Sofamor Danek USA, Inc.). The stimulation used is a train-of-five square wave stimulation, 2ms inter-stimulus interval, 500 μs width and 40-220 mA intensity which can be increased with 10 mA steps till muscle answer potential is recorded.

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

propofol sevoflurane intraoperative neurophysiological monitoring (IONM)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* (ASA) grades I-II who were scheduled for spinal surgeries (intraspinal tumors resection, spondylolisthesis correction, traumatic spinal fractures fixation….etc)

Exclusion Criteria

* Patients aged less than 18 years, or with history of drug abuse, any pulmonary disease, preoperative motor deficit, history of epilepsy, pacemakers and cochlear implants, previous intracranial surgeries or needed to deepen anesthetic plane during surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

El-Sahel Teaching Hospital

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Samir Ahmed Ahmed ElKafrawy

consultant of anesthesia, head of neuroanesthesia unit

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Samir A El kafrawy, MD

Role: PRINCIPAL_INVESTIGATOR

El-Sahel Teaching Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National cancer Institute

Cairo, , Egypt

Site Status

El sahel Teaching Hospital

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

322018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Local Anesthesia for Facial Fractures
NCT06429501 RECRUITING PHASE2